...
首页> 外文期刊>Molecular vision >Next-generation sequencing-based comprehensive molecular analysis of 43 Japanese patients with cone and cone-rod dystrophies
【24h】

Next-generation sequencing-based comprehensive molecular analysis of 43 Japanese patients with cone and cone-rod dystrophies

机译:基于下一代测序的43名日本锥和营养不良患者的全面分子分析

获取原文
           

摘要

Purpose: To investigate the efficacy of targeted exome sequencing for mutational screening of Japanese patients with cone dystrophy (CD) or cone-rod dystrophy (CRD). Methods: DNA samples from 43 Japanese patients with CD or CRD were sequenced using an exome-sequencing panel targeting all 193 known inherited eye disease genes and next-generation sequencing methodologies. Subsequently, candidate variants were screened using systematic data analyses, and their potential pathogenicity was assessed using distinct filtering approaches, which included the frequency of the variants in normal populations, in silico prediction tools, and cosegregation. Results: Causative mutations were detected in 12 patients with CD or CRD (27.9%). In total, 14 distinct mutations were identified in the genes ABCA4, CDHR1, CRB1, CRX, GUCY2D, KCNV2, PROM1, PRPH2, and RDH5, including four novel mutations, c.3050+1GA in ABCA4, c.386AG in CDHR1, c.652+1_652+4del in CRB1, and c.454GA in KCNV2. Moreover, a putative pathogenic mutation was identified in RGS9BP, a gene recognized as the source of bradyopsia. Conclusions: Targeted exome sequencing effectively identified causative mutations in Japanese patients with CD or CRD. The results confirmed the heterogeneity of the genes responsible for CD and CRD in Japanese populations, as well as the efficacy of targeted exome sequencing-based screening of patients with inherited retinal degeneration.
机译:目的:研究靶向外显子组测序对日本锥状营养不良(CD)或锥杆营养不良(CRD)患者进行突变筛查的功效。方法:使用针对所有193种已知遗传性眼病基因的外显子组测序和下一代测序方法,对来自43位日本CD或CRD患者的DNA样本进行测序。随后,使用系统的数据分析筛选候选变体,并使用不同的过滤方法评估其潜在的致病性,其中包括正常人群中变体的频率,计算机预测工具和共隔离。结果:12例CD或CRD患者中检出致病性突变(27.9%)。总共在基因ABCA4,CDHR1,CRB1,CRX,GUCY2D,KCNV2,PROM1,PRPH2和RDH5中鉴定出14个不同的突变,包括四个新突变,ABCA4中的c.3050 + 1G> A,c.386A> G CDHR1中的c.652 + 1_652 + 4del在CRB1中,而c.454G> A在KCNV2中。此外,在RGS9BP中鉴定出一个推定的致病突变,该基因被认为是慢视的来源。结论:靶向外显子组测序可有效鉴定日本CD或CRD患者的致病突变。结果证实了日本人群中负责CD和CRD的基因的异质性,以及基于靶向外显子组测序的遗传性视网膜变性患者筛查的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号